Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer

Completed · Phase 1

Conditions studied: Head and Neck Cancer

In brief

RATIONALE: Azacitidine may help thyroid cancer cells regain the ability to take up iodine. This would allow the cancer to be detected and treated by radioactive iodine. PURPOSE: Phase I trial to study the effectiveness of azacitidine to restore thyroid function in treating patients who have persistent or metastatic thyroid cancer.

Key facts

Study ID

NCT00004062

Run by

Lucille P. Markey Cancer Center at University of Kentucky

Starts

1999-07-01

Expected to finish

2006-08-01

Last updated by the study team

2013-12-19

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Albert B. Chandler Medical Center, University of Kentucky — Lexington, Kentucky, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.